Genetic aspects of valvulopathies;Aspects génétiques des valvulopathies

Archives des Maladies du Coeur et des Vaisseaux

Volumn 100, Issue 12, 2007, Pages 1013-1020

  Kyndt, F ^a   Le Scouarnec, S ^a   Jaafar, P ^a   Gueffet, J P ^a   Legendre, A ^b   Trochu, J N ^a   Jousseaume, V ^c   Chaventre A ^d   Schott, J J ^a   Le Marec, H ^a   Probst, Vincent ^a,e  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF TOURS   (France)

^c CNRS CESTAN   (France)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e Service de Cardiologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSKELETON PROTEIN; FILAMIN A;

AORTA STENOSIS; AUTOSOMAL DOMINANT INHERITANCE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 11P; CHROMOSOME 11P15.4; CHROMOSOME 13Q; CHROMOSOME 13Q31; CHROMOSOME 13Q32; CHROMOSOME 16P; CHROMOSOME 16P11; CHROMOSOME 16P12; CHROMOSOME 16P13; DISEASE TRANSMISSION; FAMILIAL DISEASE; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENETIC EPIDEMIOLOGY; HUMAN; MITRAL VALVE DISEASE; MITRAL VALVE PROLAPSE; MUTATION RATE; PATHOPHYSIOLOGY; PENETRANCE; REVIEW; SCURVY; X CHROMOSOME; X CHROMOSOME LINKED DISORDER;

CHROMOSOMES, HUMAN, X; CONTRACTILE PROTEINS; HEART VALVE DISEASES; HUMANS; MICROFILAMENT PROTEINS; MUTATION; PEDIGREE;

EID: 38749121380     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Darsee JR, Mikolich JR, Nicoloff NB, Lesser LE. Prevalence of mitral valve prolapse in presumably healthy young men. Circulation 1979 ; 59 : 619-22.
2. Levy D, Savage D. Prevalence and clinical features of mitral valve prolapse. Am Heart J 1987 ; 113 : 1281-90.
3. Glesby MJ, Pyeritz RE. Association of mitral valve prolapse and systemic abnormalities of connective tissue. A phenotypic continuum. Jama 1989 ; 262 : 523-8.
4. Disse S, Abergel E, Berrebi A, et al. Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16p11.2-p12.1. Am J Hum Genet 1999 ; 65 : 1242-51.
5. Freed LA, Acierno JS, Jr., Dai D, et al. A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4. Am J Hum Genet 2003 ; 72 : 1551-9.
6. Nesta F, Leyne M, Yosefy C, et al. New locus for autosomal dominant mitral valve prolapse on chromosome 13 : clinical insights from genetic studies. Circulation 2005 ; 112 : 2022-30.
7. Chou HT, Shi YR, Hsu Y, Tsai FJ. Association between fibrillin-1 gene exon 15 and 27 polymorphisms and risk of mitral valve prolapse. J Heart Valve Dis 2003 ; 12 : 475-81.
8. Monteleone PL, Fagan LF. Possible X-linked congenital heart disease. Circulation 1969 ; 39 : 611-4.
9. Kyndt F, Schott JJ, Trochu JN, et al. Mapping of X-linked myxomatous valvular dystrophy to chromosome Xq28. Am J Hum Genet 1998 ; 62 : 627-32.
10. Trochu JN, Kyndt F, Schott JJ, et al. Clinical characteristics of a familial inherited myxomatous valvular dystrophy mapped to Xq28. J Am Coll Cardiol 2000 ; 35 : 1890-7.
11. Moro F, Carrozzo R, Veggiotti P, et al. Familial periventricular heterotopia : missense and distal truncating mutations of the FLN1 gene. Neurology 2002 ; 58 : 916-21.
12. Kyndt F, Gueffet JP, Probst V, et al. Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy. Circulation 2007 ; 115 : 40-9.
13. Hart AW, Morgan JE, Schneider J, et al. Cardiac malformations and midline skeletal defects in mice lacking filamin A. Hum Mol Genet 2006 ; 15 : 2457-67.
14. Feng Y, Chen MH, Moskowitz IP, et al. Filamin A (FLNA) is required for cell-cell contact in vascular development and cardiac morphogenesis. Proc Natl Acad Sci USA 2006 ; 103 : 19836-41.
15. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997 ; 29 : 630-4.
16. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease : pathogenesis, disease progression, and treatment strategies. Circulation 2005 ; 111 : 3316-26.
17. Ortlepp JR, Hoffmann R, Ohme F, Lauscher J, Bleckmann F, Hanrath P. The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart 2001 ; 85 : 635-8.
18. Ortlepp JR, Pillich M, Mevissen V, et al. APOE alleles are not associated with calcific aortic stenosis. Heart 2006 ; 92 : 1463-6.
19. Novaro GM, Sachar R, Pearce GL, Sprecher DL, Griffin BP. Association between apolipoprotein e alleles and calcific valvular heart disease. Circulation 2003 ; 108 : 1804-8.
20. Garg V, Muth AN, Ransom JF, et al. Mutations in NOTCH1 cause aortic valve disease. Nature 2005 ; 437 : 270-4.
21. Mohamed SA, Aherrahrou Z, Liptau H, et al. Novel missense mutations (p. T596M and p. P1797H) in NOTCH1 in patients with bicuspid aortic valve. Biochem Biophys Res Commun 2006 ; 345 : 1460-5.
22. Probst V, Kyndt F, Potet F, et al. Haploinsufficiency in combination with aging causes SCN5A-linked hereditary Lenegre disease. J Am Coll Cardiol 2003 ; 41 : 643-52.
23. Schott JJ, Alshinawi C, Kyndt F, et al. Cardiac conduction defects associate with mutations in SCN5A. Nat Genet 1999 ; 23: 20-1.
24. Probst V, Kyndt F, Allouis M, Schott JJ, Le Marec H. [Genetic aspects of cardiac conduction defects]. Arch Mal Coeur Vaiss 2003 ; 96 : 1067-73.
25. Bella JN, Tang W, Kraja A, et al. Genome-wide linkage mapping for valve calcification susceptibility loci in hypertensive sib-ships : the Hypertension Genetic Epidemiology Network Study. Hypertension 2007 ; 49 : 453-60.
26. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease : The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007 ; 28 : 230-68.